Tom Home Page

Tom Home Page

Our platform represents a fundamentally new approach to immunotherapy. Our therapies have the potential to offer a cure for patients with the most difficult to treat hematologic conditions.
Lukas Home Page

Lukas Home Page

We have the ability to specifically edit a cell surface receptor to completely prevent antibody binding while keeping the receptor fully functional. Instead of removing a target entirely, this type of epitope editing has the potential to allow the shielding of any...